ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,169.09
0.07%
Dow Jones
38,647.10
-0.17%
Gold vs US Dollar
2,313.425
0.47%
Brent Oil
82.105
0.16%
Bitcoin
66,845.94
0.13%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Eagle Pharmaceuticals Inc (EGRX)

  7. Eagle Pharmaceuticals Inc (EGRX) News

Eagle Pharmaceuticals (EGRX)

Eagle Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EGRX
DateTimeSourceHeadlineSymbolCompany
29/05/202413:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
22/05/202414:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
15/05/202414:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
10/05/202422:27Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:EGRXEagle Pharmaceuticals Inc
08/03/202421:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
01/03/202421:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
01/03/202412:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
01/03/202401:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
29/02/202421:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
29/02/202413:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
14/02/202422:09Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:EGRXEagle Pharmaceuticals Inc
13/02/202420:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
13/02/202413:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
12/02/202418:38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EGRXEagle Pharmaceuticals Inc
09/02/202410:45PR Newswire (US)Eagle Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 9, 2024 to Discuss Your Rights - EGRXNASDAQ:EGRXEagle Pharmaceuticals Inc
07/02/202414:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EGRXEagle Pharmaceuticals Inc
06/02/202422:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
02/02/202410:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
26/01/202416:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
26/01/202410:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
19/01/202410:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
18/01/202411:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
18/01/202411:50GlobeNewswire Inc.Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property PortfolioNASDAQ:EGRXEagle Pharmaceuticals Inc
16/01/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
12/01/202410:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
09/01/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
09/01/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
05/01/202410:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
23/12/202300:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
22/12/202322:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:EGRX

Your Recent History

LSE
SCLP
Scancell
LSE
PANR
Pantheon Resources
LSE
AAZ
Anglo Asian Mining
LSE
GDR
Genedrive
LSE
LLOY
Lloyds Banking
LSE
HE1
Helium One Global
LSE
RPI
Raspberry Pi
LSE
TERN
Tern
LSE
ENET
Ethernity Networks
LSE
ITM
Itm Power
LSE
GKP
Gulf Keystone Petroleum
LSE
LGEN
Legal & General
LSE
QED
Quadrise
LSE
POS
Plexus
LSE
SQZ
Serica Energy
LSE
CHLL
Chill Brands
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved